Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 115,516 | 58,359 | 0 | N/A |
| Marketable Securities | 274,101 | 50,845 | 0 | N/A |
| TOTAL | $402,995 | $117,783 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 16,308 | 12,290 | 0 | N/A |
| Investments And Advances | 24,290 | 0 | 0 | 0 |
| Intangibles | 52,631 | 53,854 | 0 | 0 |
| Other Non-Current Assets | 15,847 | 7,669 | 0 | 0 |
| TOTAL | $109,076 | $73,813 | $N/A | $N/A |
| Total Assets | $512,071 | $191,596 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 5,881 | 6,473 | 0 | 0 |
| Accrued Expenses | 26,495 | 14,534 | 0 | N/A |
| Other current liabilities | 20,649 | 10,140 | 0 | N/A |
| TOTAL | $59,206 | $39,908 | $0 | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 6,181 | 8,761 | N/A | N/A |
| Other Non-Current Liabilities | 12,948 | 320,999 | 0 | 0 |
| TOTAL | $28,923 | $330,865 | $N/A | $N/A |
| Total Liabilities | $88,129 | $370,773 | $0 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 109,800 | N/A | N/A | N/A |
| Common Shares | 11 | 1 | 0 | N/A |
| Retained earnings | -368,519 | -193,836 | 0 | N/A |
| Other shareholders' equity | -601 | -14 | 0 | 0 |
| TOTAL | $423,942 | $-179,177 | $0 | $N/A |
| Total Liabilities And Equity | $512,071 | $191,596 | $0 | $0 |